All Blue Capital
is a private equity firm that invests in early and growth stage technology companies... Read moreAll Blue Capital
is a private equity firm that invests in early and growth stage technology companies... Read more
News
May 20, 2022
Saltwire
All Blue Capital: Cancer drug developer Zymeworks rejects All Blue Capital's $773 million bid | SaltWire
May 19, 2022
Markets Insider
All Blue Capital: ALL BLUE CAPITAL EXPANDS ITS LEADERSHIP TEAM TO SUPPORT PROPOSED ACQUISITION OF ZYMEWORKS INC.
May 04, 2022
FirstWord Pharma
All Blue Capital: All Blue Capital Announces Leadership To Support Proposed Acquisition Of Zymeworks, Inc.
May 03, 2022
Nasdaq
All Blue Capital: Former AstraZeneca oncology head to help All Blue in Zymeworks takeover bid
Apr 29, 2022
BioSpace
All Blue Capital: Zymeworks Mulls $733 Million Bid from All Blue Capital
Apr 28, 2022
Nasdaq
All Blue Capital: EXCLUSIVE-All Blue Capital in $773 mln bid for Zymeworks -sources
Mar 02, 2022
GlobalNewswire
Press Release: All Blue Capital : All Blue Capital Announces New Global Headquarters in Dubai International Financial Centre, Dubai, UAE